-+ 0.00%
-+ 0.00%
-+ 0.00%
BSF Enterprise Secures Global Exclusive Commercialization, Supply Deal for Bioactive Peptide
Share
Listen to the news
03:53 AM EDT, 08/11/2026 (MT Newswires) -- BSF Enterprise (BSFA.L) signed a heads of terms agreement with Schakau Managementberatung for a worldwide, exclusive commercialization and supply partnership for its bioactive peptide ETSYL, palmitoyl pentapeptide-87. The British tissue-engineered materials company granted the German boutique commercialization company commercialization, distribution and licensing rights for the peptide across the cosmetics, skincare, dermocosmetics and luxury beauty sectors for an initial 10 years, subject to annual targets, according to a Tuesday filing. Schakau will deploy ETSYL as the core active ingredient in its ultra-luxury skincare brand, Hands of God, and seek ingredient licensing deals with global cosmetic brand partners.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending